Nick Leschly
CIK 1578408 · President and CEO · last filed 2025-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLUE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| bluebird bio, Inc. (BLUE) Delisted | Director | 1,245 | $4.97 | $6.2K | -$78.45M | 59 | 2025-06-03 |
| 2seventy bio, Inc. (TSVT) Delisted | President and CEO | 1,248,839 | $5.00 | $6.24M | $3.49M | 16 | 2025-01-07 |
| SYNLOGIC, INC. (SYBX) Delisted | Director | — | $0.69 | — | $0 | 8 | 2023-06-26 |
Recent Filings · Page 2 of 9
84 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-03 | 2seventy bio, Inc. (TSVT) Delisted | Grant (A) | +509,821 | $0 | EDGAR |
| 2023-01-18 | 2seventy bio, Inc. (TSVT) Delisted | Sell (S) | −2,026 | -$21.5K | EDGAR |
| 2023-01-17 | 2seventy bio, Inc. (TSVT) Delisted | Sell (S) | −6,587 | -$68.9K | EDGAR |
| 2023-01-13 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −4,290 | -$33.5K | EDGAR |
| 2023-01-11 | 2seventy bio, Inc. (TSVT) Delisted | Sell (S) | −2,979 | -$30.8K | EDGAR |
| 2022-08-08 | 2seventy bio, Inc. (TSVT) Delisted | Sell (S) | −5,499 | -$89.3K | EDGAR |
| 2022-07-19 | 2seventy bio, Inc. (TSVT) Delisted | Sell (S) | −5,404 | -$74.6K | EDGAR |
| 2022-06-23 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +3,109 | $0 | EDGAR |
| 2022-06-13 | SYNLOGIC, INC. (SYBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-05 | 2seventy bio, Inc. (TSVT) Delisted | Grant (A) | +133,500 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.